+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bronchodilators - Global Strategic Business Report - Product Thumbnail Image

Bronchodilators - Global Strategic Business Report

  • Report
  • March 2026
  • 282 Pages
  • Global
From
From
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
Liver Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 277 Pages
  • Global
From
Microbiome Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Microbiome Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 200 Pages
  • Global
From
Schizophrenia Market Report 2026 - Product Thumbnail Image

Schizophrenia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • March 2026
  • 93 Pages
  • Global
From
From
Loading Indicator